Wuhan starts the "dual channel" management of negotiation drugs, 71 kinds of drugs can be used in hospital pharmacies to apply for medical insurance

In the pharmaceutical market, some drugs, especially oncology and rare disease drugs, are expensive.
In recent years, with the advancement of medical insurance negotiations, many "high-priced drugs" have entered the medical insurance catalog, bringing relief medicines to relevant patients.
A costly gospel
.
However, some patients also found that although the prices of some medicines have fallen, they cannot be bought in hospitals and can only buy them at pharmacies at their own expense
.
In order to solve the problem of "difficulty in entering hospitals" for medical insurance negotiation drugs, the two ministries and commissions of the Wuhan Municipal Medical Insurance Bureau issued a notice a few days ago to clearly include designated pharmacies in the scope of the medical insurance negotiation drug supply guarantee, forming a "dual channel" with designated medical institutions.
And implement unified payment to better meet the needs of the insured persons for rational drug use
.
It is reported that Wuhan has clearly included 71 medical insurance negotiation drugs into the "dual channel" management this time, and will implement dynamic adjustments according to changes in the situation
.
Among the 71 drugs, most of them are oncology drugs, and the number is 41.
They are all negotiated drugs with high clinical value, urgent need by patients, and low substitutes and innovative drugs
.
Wuhan City made it clear that from November 20th, insured persons in Wuhan will purchase “dual-channel” drugs in two “dual-channel” designated retail pharmacies in the city as required, and they can implement the same medical insurance payment policy as designated medical institutions.
The personnel only pay for the expenses borne by themselves
.
In other words, from November 20th, local insured personnel can purchase medicines in the "dual channel" with medical insurance at hospital pharmacies, which is undoubtedly great news for patients
.
On May 10, 2021, the National Medical Insurance Administration issued the "Guiding Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for National Medical Insurance Negotiation Drugs", which clearly included designated retail pharmacies in the scope of negotiated drug supply guarantees, and formed negotiations with designated medical institutions The "dual channel" of drug reimbursement ensures the smooth implementation of drugs under the national medical insurance negotiations
.
In addition to Hubei Province where Wuhan is located, Hunan, Fujian, Guangdong, Jiangsu, Zhejiang, Anhui, Henan, Hebei, Hubei, Jiangxi, Shanxi and other provinces have successively issued documents to implement the establishment of a "dual channel" management mechanism, and there are many Provinces and cities listed the first batch of catalogues included in the "dual-channel" drug management
.
For example, on August 26, the Hunan Provincial Medical Insurance Bureau and the Hunan Provincial Health Commission jointly issued the "Hunan Provincial Medical Insurance Negotiation Drug "Dual Channel" Management Measures", which will be implemented on September 1, 2021
.
Subsequently, on October 12, the Hunan Medical Insurance Bureau issued the "Announcement on the First Batch of "Dual Channel" Management Drugs in Hunan Province in 2021", with a total of 49 drugs
.
Including 40 Western medicines and 9 Chinese patent medicines
.
On September 2, the Fujian Medical Insurance Bureau issued a document to establish a “dual-channel” management mechanism for provincial and state talks drugs, which will be implemented on November 1, 2021
.
The first batch of "dual-channel" controlled drug catalogs published by the province contains a total of 32 drugs, including sinimod, adalimumab, deuterium tetrabenazine and other drugs
.
On September 15, the Guangdong Medical Insurance Bureau and other three ministries issued the "Implementation Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for Drugs in National Medical Insurance Negotiations", suggesting that designated medical institutions should give priority to purchasing and using "dual channel" drugs
.
On October 19, the Guangdong Provincial Medical Insurance Bureau issued the "Dual Channel" Management Drug Scope in Guangdong Province (2021), which included a total of 221 drugs
.
For patients, with the implementation of the “dual-channel” management mechanism for drugs in the national medical insurance negotiations, patients will alleviate the hospital’s “difficult to see a doctor” problem, enjoy the “dual-channel” management of drugs, meet the urgent need for medication, and at the same time alleviate the national drug negotiation.
The nervousness of "difficulty in entering the hospital"
.